What is AZN's current stock price?

As of now, AZN is trading at $84.58, with a daily change of +0.97%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

AZN Stock Analysis & IQ Rating | Astrazeneca

AZN SYMBOL Badge

Astrazeneca

$84.58

+$0.81 | +0.97%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$ 86.57

MKT CAP

$ 263.48B

52W Low

$ 61.24

VOL

$ 4.10M

P/E Ratio

28.1

AVG VOL

$ 5.57M

RSI

59.88

TREND

Uptrend

AZN Stock IQ

Login to see Astrazeneca (AZN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

AZN Target Price

Login to display

Strengths

AZN Rewards

Earnings are forecast to grow

AZN Rewards

Upgraded on attractively valued

AZN Rewards

Trading below its fair value

AZN Rewards

Outperform the market

Chart

$84.51 (+0.08%)

$79.17 (+6.83%)

$70.76 (+19.53%)

$64.26 (+31.62%)

1year

6month

3month

1month

AZN Risk Level

AZN has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

AZN Analysts Opinion

AZN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

AZN Analysts Opinion

AZN Analysts opinion is positive and also has improved from the past 3 months

AZN Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

94%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

83%

100%

AZN Street Sentiment

AZN Street Sentiment is extremely bullish and have positive views on the near-term outlook

AZN Performance Sentiment

Sentiments overview associated with AZN events and the stock performance.

94%

6%

Positive

Negative

32 out of 34
events present

2 out of 34
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$83.77

Resistance
Price

$73.53

Current Price Range

$85.12

Show methods +

Linked to AZN

IQ

Close Price

Change

NVS

3.85

126.35

-0.15%

PFE

3.84

24.43

+0.04%

MRK

3.96

86.28

+0.58%

SNY

4.24

49.66

+0.34%

LLY

4.17

924.37

-1.39%

AZN Latest Analysis +

AstraZeneca PLC (NASDAQ:AZN) Q3 2025 Earnings Call Transcript. AstraZeneca PLC (NASDAQ:AZN) Q3 2025 Earnings Call Transcript November 6 2025 AstraZeneca PLC beats earnings expectations. Reported EPS is $1.19 expectations were $1.14. Operator: Good afternoon and welcome to AstraZeneca’.s 9 months and Q3 2025 webinar for investors and analysts. Before I hand over to AstraZeneca I’.d like to read the Safe Harbor Statement. The [….]

Fri Nov 7, 2025

$84.58 | +0.97%

Earnings

Why AstraZeneca Stock Topped the Market on Thursday. Key PointsThe global pharmaceutical giant posted some impressive growth numbers in its latest earnings release.

Thu Nov 6, 2025

$83.77 | +3.23%

Potential

AstraZeneca: Solid Results But Risks Emerge (Rating Downgrade).

Thu Nov 6, 2025

$83.77 | +3.23%

Earnings

Compared to Estimates Astrazeneca (AZN) Q3 Earnings: A Look at Key Metrics. Although the revenue and EPS for Astrazeneca (AZN) give a sense of how its business performed in the quarter ended September 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Thu Nov 6, 2025

$83.77 | +3.23%

Potential

AZN Q3 Earnings Top Estimates Sales Rise As Most Key Drugs Outperform. AstraZeneca posts strong Q3 results. Core earnings and revenues beat estimates as key drugs like Tagrisso Imfinzi and Farxiga fuel broad-based growth.

Thu Nov 6, 2025

$83.77 | +3.23%

Earnings

Potential

AstraZeneca Bounds Into A Chase Zone As Cancer Drugs Drive Sales Beat. AstraZeneca stock bounded into a buy zone Thursday after sales of its cancer drugs beat Wall Streets expectations by about 5%.The post AstraZeneca Bounds Into A Chase Zone As Cancer Drugs Drive Sales Beat appeared first on Investor'.s Business Daily.

Thu Nov 6, 2025

$83.77 | +3.23%

Earnings

AstraZeneca Calms Pricing Jitters Says US Deal Hit Absorbable. ) on Thursday reported third-quarter 2025 sales of $15.19 billion up 12% year over year (10% at constant currency) beating the driven by double-digit growth in oncology CVRM and biopharmaceuticals.The company’.s adjusted EPADS reached $1.19 beating the consensus of $1.14. The adjusted EPS was $2.38 (1 ADR = 2 Common Shares).AstraZeneca’.s cancer business accounted for 44% of total sales. It 19% (up 18% on constant currenc

Thu Nov 6, 2025

$83.77 | +3.23%

Potential

AstraZeneca Shares Jump. Drugmaker Keeps Outlook As Cancer Drug Sales Soar. AstraZeneca stock jumped Thursday after the drugmaker reported better-than-expected third-quarter sales and earnings.The post AstraZeneca Shares Jump. Drugmaker Keeps Outlook As Cancer Drug Sales Soar appeared first on Investor'.s Business Daily.

Thu Nov 6, 2025

$83.77 | +3.23%

Activity

Momentum

AstraZeneca beats Q3 estimates on oncology strength.

Thu Nov 6, 2025

$83.77 | +3.23%

Earnings

AstraZeneca beats top-line and bottom-line estimates. reaffirms FY25 outlook.

Thu Nov 6, 2025

$83.77 | +3.23%

Earnings

FAQ About AZN Stock Insights

What is AZN current stock price?

What are AZN stock strengths?

What risks are associated with AZN stock?

When is AZN next earnings report?

What is AZN market cap and volume?

What is AZN's current Stock IQ?

Should I buy AZN stock right now?

Is AZN a Strong Buy right now?

What does a 'Strong Buy' rating mean for AZN?

What does a 'Strong Sell' rating mean for AZN?

What factors influence AZN's Stock IQ?

Explore our AZN Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored AZN Stock Strategies
Effective Risk Management

FIND US ON

Receive our AZN Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

AZN AZN Badge

Astrazeneca

Current Price

$84.58

+$0.81 | +0.97%

52W High

$ 86.57

MKT CAP

$ 263.48B

52W Low

$ 61.24

VOL

$ 4.10M

P/E Ratio

28.1

AVG VOL

$ 5.57M

RSI

59.88

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

AZN Rewards

Earnings are forecast to grow

AZN Rewards

Upgraded on attractively valued

AZN Rewards

Trading below its fair value

AZN Rewards

Outperform the market

Linked to AZN

Symbol

IQ

Close

Change

NVS

3.85

126.35

-0.15%

PFE

3.84

24.43

+0.04%

MRK

3.96

86.28

+0.58%

SNY

4.24

49.66

+0.34%

LLY

4.17

924.37

-1.39%

AZN Stock IQ

Login to unlock Astrazeneca (AZN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$84.51 (+0.08%)

$79.17 (+6.83%)

$70.76 (+19.53%)

$64.26 (+31.62%)

1year

6month

3month

1month

AZN Analysts Opinion

AZN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

AZN Analysts Opinion

AZN Analysts opinion is positive and also has improved from the past 3 months

AZN Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

94%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

83%

100%

AZN Street Sentiment

AZN Street Sentiment is extremely bullish and have positive views on the near-term outlook

AZN Risk Level

AZN has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

AZN Performance Sentiment

Sentiments overview associated with AZN events and the stock performance.

94%

6%

Positive

Negative

32 out of 34
events present

2 out of 34
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$83.77

Resistance
Price

$73.53

Current Price Range

$85.12

Show methods +

AZN Latest Analysis

AstraZeneca PLC (NASDAQ:AZN) Q3 2025 Earnings Call Transcript. AstraZeneca PLC (NASDAQ:AZN) Q3 2025 Earnings Call Transcript November 6 2025 AstraZeneca PLC beats earnings expectations. Reported EPS is $1.19 expectations were $1.14. Operator: Good afternoon and welcome to AstraZeneca’.s 9 months and Q3 2025 webinar for investors and analysts. Before I hand over to AstraZeneca I’.d like to read the Safe Harbor Statement. The [….]

Fri Nov 7, 2025

$84.58 | +0.97%

Earnings

Why AstraZeneca Stock Topped the Market on Thursday. Key PointsThe global pharmaceutical giant posted some impressive growth numbers in its latest earnings release.

Thu Nov 6, 2025

$83.77 | +3.23%

Potential

AstraZeneca: Solid Results But Risks Emerge (Rating Downgrade).

Thu Nov 6, 2025

$83.77 | +3.23%

Earnings

Compared to Estimates Astrazeneca (AZN) Q3 Earnings: A Look at Key Metrics. Although the revenue and EPS for Astrazeneca (AZN) give a sense of how its business performed in the quarter ended September 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Thu Nov 6, 2025

$83.77 | +3.23%

Potential

AZN Q3 Earnings Top Estimates Sales Rise As Most Key Drugs Outperform. AstraZeneca posts strong Q3 results. Core earnings and revenues beat estimates as key drugs like Tagrisso Imfinzi and Farxiga fuel broad-based growth.

Thu Nov 6, 2025

$83.77 | +3.23%

Earnings

Potential

AstraZeneca Bounds Into A Chase Zone As Cancer Drugs Drive Sales Beat. AstraZeneca stock bounded into a buy zone Thursday after sales of its cancer drugs beat Wall Streets expectations by about 5%.The post AstraZeneca Bounds Into A Chase Zone As Cancer Drugs Drive Sales Beat appeared first on Investor'.s Business Daily.

Thu Nov 6, 2025

$83.77 | +3.23%

Earnings

AstraZeneca Calms Pricing Jitters Says US Deal Hit Absorbable. ) on Thursday reported third-quarter 2025 sales of $15.19 billion up 12% year over year (10% at constant currency) beating the driven by double-digit growth in oncology CVRM and biopharmaceuticals.The company’.s adjusted EPADS reached $1.19 beating the consensus of $1.14. The adjusted EPS was $2.38 (1 ADR = 2 Common Shares).AstraZeneca’.s cancer business accounted for 44% of total sales. It 19% (up 18% on constant currenc

Thu Nov 6, 2025

$83.77 | +3.23%

Potential

AstraZeneca Shares Jump. Drugmaker Keeps Outlook As Cancer Drug Sales Soar. AstraZeneca stock jumped Thursday after the drugmaker reported better-than-expected third-quarter sales and earnings.The post AstraZeneca Shares Jump. Drugmaker Keeps Outlook As Cancer Drug Sales Soar appeared first on Investor'.s Business Daily.

Thu Nov 6, 2025

$83.77 | +3.23%

Activity

Momentum

AstraZeneca beats Q3 estimates on oncology strength.

Thu Nov 6, 2025

$83.77 | +3.23%

Earnings

AstraZeneca beats top-line and bottom-line estimates. reaffirms FY25 outlook.

Thu Nov 6, 2025

$83.77 | +3.23%

Earnings

Discover AZN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AZN. We're here to help you make informed investment decisions today.

FIND US ON

Receive our AZN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AZN Stock trends

AZN Stock performance

AZN Stock analysis

AZN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AZN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AZN

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

AZN Stock Analysis & IQ Rating | Astrazeneca

AZN Stock IQ

AZN Target Price

AZN Risk Level

AZN Analysts Opinion

AZN Street Sentiment

AZN Performance Sentiment

Technical Price Levels

Explore our AZN Stock insights

Receive our AZN Daily Alerts

AZN Stock IQ

AZN Street Sentiment

AZN Risk Level

Technical Price Levels

Discover AZN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AZN. We're here to help you make informed investment decisions today.

Receive our AZN Daily Alerts

AZN Runner Alarm